PKD Cures Act
Key claim: The PKD Cures Act (HR9169, 119th Congress) has been introduced and referred to the House Committee on Energy and Commerce.
Abstract
(HR9169 · 119th Congress) Latest action (2026-06-04): Referred to the House Committee on Energy and Commerce.
Why this matters
The PKD Cures Act signals congressional attention to polycystic kidney disease research, a chronic condition that often progresses to end-stage renal disease requiring dialysis or transplant. As an introduced bill referred to committee, it carries no immediate change to coverage, FDA pathways, or research funding, but it establishes a legislative marker to track for potential downstream effects on rare disease research policy.